The Administrative Core is charged with leadership, oversight, fiscal, and general administrative responsibility for the Oregon Alzheimer Disease Center (OADC). The OADC Director works closely with the Executive Committee of the Center, which is composed of all the Core Leaders and other key OADC personnel. The Administrative Core coordinates the six cores of the Center through structured, regular meetings and interim reports. Members of individual Cores, having duties and necessary interactions within other related units of the Center, facilitate the integration of the OADC on a daily basis. In addition to managerial and supervisory duties, the Administrative Core also seeks to ensure that the OADC is positioned to respond to the needs of the greater community of scientists and other interested individuals engaged in activities relevant to research on Alzheimer disease and related disorders, especially as they relate to uncompromised brain aging and incipient or early dementia. This includes advising and encouraging young investigators, as well as relating to the concerns and requirements of established scientists with regard to their research. The Core also seeks to foster the movement of talented investigators from other fields into the brain aging and dementia arena. This process is facilitated by the OADC Pilot Project Grant mechanism organized annually by the Administrative Core. Overview of the general direction and quality of the Center is achieved through oversight and advice of the National Institute on Aging and two committees: the External and Internal Advisory Committees. The External Review process brings in an outside External Review Committee of experts to critically review the progress of the Center and issue a formal report. Similarly, but with a different, yet complementary perspective, the Internal Advisory Committee (composed of prominent local scientists and community leaders) also provides review and oversight to the OADC. Members of both review committees are also used to advise the OADC Director and Core Leaders on an as needed basis as well.

Public Health Relevance

The Administrative Core of the Oregon Alzheimer Disease Center provides the necessary organizational structure, scientific direction and leadership to effectively operate the entire research center. In providing oversight and stewardship of the overall mission of the center sound fiscal, scientific and educational policies and practices are achieved targeted toward the goal of understanding the causes of dementia and ultimately their treatments.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
5P30AG008017-23
Application #
8458384
Study Section
Special Emphasis Panel (ZAG1-ZIJ-4)
Project Start
Project End
Budget Start
2012-05-01
Budget End
2013-03-31
Support Year
23
Fiscal Year
2012
Total Cost
$120,063
Indirect Cost
$42,099
Name
Oregon Health and Science University
Department
Type
DUNS #
096997515
City
Portland
State
OR
Country
United States
Zip Code
97239
Hanfelt, John J; Peng, Limin; Goldstein, Felicia C et al. (2018) Latent classes of mild cognitive impairment are associated with clinical outcomes and neuropathology: Analysis of data from the National Alzheimer's Coordinating Center. Neurobiol Dis 117:62-71
Zhou, Zilu; Wang, Weixin; Wang, Li-San et al. (2018) Integrative DNA copy number detection and genotyping from sequencing and array-based platforms. Bioinformatics 34:2349-2355
Burke, Shanna L; Hu, Tianyan; Fava, Nicole M et al. (2018) Sex differences in the development of mild cognitive impairment and probable Alzheimer's disease as predicted by hippocampal volume or white matter hyperintensities. J Women Aging :1-25
Wang, Qi; Guo, Lei; Thompson, Paul M et al. (2018) The Added Value of Diffusion-Weighted MRI-Derived Structural Connectome in Evaluating Mild Cognitive Impairment: A Multi-Cohort Validation1. J Alzheimers Dis 64:149-169
Teipel, Stefan; König, Alexandra; Hoey, Jesse et al. (2018) Use of nonintrusive sensor-based information and communication technology for real-world evidence for clinical trials in dementia. Alzheimers Dement 14:1216-1231
Wang, Tingyan; Qiu, Robin G; Yu, Ming (2018) Predictive Modeling of the Progression of Alzheimer's Disease with Recurrent Neural Networks. Sci Rep 8:9161
Agogo, George O; Ramsey, Christine M; Gnjidic, Danijela et al. (2018) Longitudinal associations between different dementia diagnoses and medication use jointly accounting for dropout. Int Psychogeriatr 30:1477-1487
Wardzala, Casia; Murchison, Charles; Loftis, Jennifer M et al. (2018) Sex differences in the association of alcohol with cognitive decline and brain pathology in a cohort of octogenarians. Psychopharmacology (Berl) 235:761-770
Alosco, Michael L; Sugarman, Michael A; Besser, Lilah M et al. (2018) A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology. J Alzheimers Dis 63:1347-1360
Brent, Robert J (2018) Estimating the monetary benefits of medicare eligibility for reducing the symptoms of dementia. Appl Econ 50:6327-6340

Showing the most recent 10 out of 482 publications